A3P Biomedical has appointed Andreas Hoel as VP Marketing & Sales. Andreas Hoel brings more than 20 years´ experience from marketing and sales positions in the life science, diagnostics and medical device industries, most recently at Thermo Fisher in the UK. He joins A3P today and reports to CEO David Rosén.
“I am very pleased that we have been able to recruit Andreas Hoel as our new VP Marketing & Sales. With broad experience from the industry and several challenging positions managing sales and marketing teams, Andreas will be a key member of the management team when we accelerate our commercialization efforts in Europe,” says David Rosén CEO of A3P Biomedical.
“I really look forward to leveraging my experience from the diagnostics industry to broaden the use of Stockholm3. The clinical evidence is very strong, showing that Stockhokm3 can significantly improve the care of prostate cancer patients by finding more cases of aggressive cancer and at the same time reduce overtreatment. This has the potential to save lives, improve the quality of life for the patients and at the same time save money for the healthcare system, which is a highly attractive proposition,” says Andreas Hoel.
Andreas Hoel is 48 years old and holds an M.Sc. in Chemistry from the Technical University of Denmark and an MBA from Henley Management College. Most recently he has served as Senior Director Customer Experience at Thermo Fisher Scientific. Previously he has, for example, been commercialization lead for Thermo Fisher products, been responsible for diagnostic product lines at Dako and served as sales manager and product manager at Biotage.